Support and Outreach to Increase Screening for Lung Cancer in Patients With a History of Smoking
NCT ID: NCT05679349
Last Updated: 2025-05-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
822 participants
INTERVENTIONAL
2024-04-01
2027-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multilevel Interventions to Increase Adherence to Lung Cancer Screening
NCT05747443
Proactive Outreach and Shared Decision Making in Improving Lung Cancer Screening Rates in Primary Care Patients
NCT03929926
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
NCT04675476
Lung Cancer Screening: A Multilevel Intervention
NCT03862001
Precision Prevention Strategy to Increase Uptake and Engagement in Lung Cancer Screening and Smoking Cessation Treatment
NCT05627674
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. Assess intervention impact on lung cancer screening (LCS). II. Assess intervention impact on shared decision making (SDM).
SECONDARY OBJECTIVES:
I. Identify mediators and moderators of LCS. II. Assess intervention implementation barriers and facilitators.
EXPLORATORY OBJECTIVES:
I. Assess intervention impact on:
Ia. LCS referral; Ib. Tobacco treatment services referral; Ic. Repeat annual LCS among participants with a normal initial screening result; Id. Follow-up diagnostic evaluation for participants with an abnormal screening result.
OUTLINE: Providers are randomized to 1 of 2 groups. Patients are randomized to 1 of 2 groups.
PROVIDERS:
GROUP A: PROVIDER SUPPORT GROUP: Participants complete survey on study. Participants undergo online educational activity on study. Participants undergo distance learning on study.
GROUP B: PROVIDER CONTROL GROUP: Participants complete survey at baseline and end of study survey.
PATIENTS:
GROUP A: Patients undergo electronic health records (EHR) review on study. Patients undergo educational activity on study. Patients also undergo SDM counseling once on study.
GROUP B: Patients undergo EHR review on study and complete telephone survey throughout the trial.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
SCREENING
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A (Providers): (survey, online educational activity)
Participants complete survey on study. Participants undergo online educational activity on study. Participants undergo distance learning on study.
Survey Administration
Complete survey
Educational Activity
Undergo online shared decision making training and distance learning
Group B (Providers): (survey)
Participants complete survey at baseline and end of study survey.
Survey Administration
Complete survey
Group A (Patients): (EHR, educational activity, counseling))
Patients undergo EHR review on study. Patients undergo educational activity on study. Patients also undergo SDM counseling once on study.
Electronic Health Record Review
Undergo electronic health record review
Educational Activity
Undergo online shared decision making training and distance learning
Counseling
Undergo shared decision making counseling
Group B (Patients): (survey)
Patients undergo EHR review on study and complete telephone survey throughout the trial.
Survey Administration
Complete survey
Electronic Health Record Review
Undergo electronic health record review
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Survey Administration
Complete survey
Educational Activity
Undergo online shared decision making training and distance learning
Survey Administration
Complete survey
Electronic Health Record Review
Undergo electronic health record review
Educational Activity
Undergo online shared decision making training and distance learning
Counseling
Undergo shared decision making counseling
Survey Administration
Complete survey
Electronic Health Record Review
Undergo electronic health record review
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Primary care practice (family medicine, geriatrics, internal medicine) in one of the 4 participating health systems
* Practice using the main electronic medical record (EMR) of each system, in order to run appropriate patient recruitment reports
* Practice with at least 50% of practice providers (physicians and advanced care providers) consenting to participate
* PATIENT LEVEL:
* Have an office or telemedicine established patient visit scheduled with a primary care provider in one of the participating practices within next 14 to 25 days
* 50 to 77 years of age
* Have at least a 20-pack-year smoking history (based on self-report at baseline eligibility assessment)
* Currently smoke or have quit smoking within the past 15 years (based on self-report at baseline eligibility assessment)
* Able to communicate in English or Spanish (determined at baseline eligibility assessment)
Exclusion Criteria
* Any lung computed tomography (CT) or low-dose computed tomography (LDCT) scan in the past 11 months, current procedural terminology (CPT) Codes are as follows
* G0297 - LDCT screening
* 71250 - CT w/o contrast
* 71260 - CT w/ contrast
* 71270 - CT with and w/o contrast
* 71275 - CT angiography chest
* 78815 - Positron emission tomography computed tomography (PET CT) skull base to mid-thigh
* 78816 - PET CT whole body
* Prior history of lung cancer (The patient's problem list includes a problem with an international classification of diseases (ICD10) code of "Z85.118" or one beginning with "C34.", or by self-report at baseline eligibility assessment)
* Recent hospitalization (Admission date within the last 60 days listed in electronic health record (EHR), or by self-report at baseline eligibility assessment)
* Dementia (diagnosis codes F03.90 or F03.91) in EHR
50 Years
77 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
Ronald Myers
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ronald Myers
Professor - Medical Oncology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sidney Kimmel Cancer Center at Thomas Jefferson University
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Ronald Myers
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
JT 24704
Identifier Type: OTHER
Identifier Source: secondary_id
22F.808
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.